Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee
Status:
Terminated
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This study was a double-blind, randomized, parallel group, proof of concept study comparing
FX006 to Kenalog®-40 (triamcinolone acetonide injectable suspension, USP) in patients with
post-traumatic osteoarthritis of the knee.